Collaborators

Corporate members, scientific collaborators, and commerical partners of the iSAEC join together to pool resources, data and expertise to investigate rare severe adverse reactions to drugs. This research is coordinated and guided by regularly formulated research plans. To date, the iSAEC has developed two research plans, one for each of its "phases": 

The iSAEC's corporate Members (for both phase 1 and phase 2 to date) are listed below:

The iSAEC's Scientific Collaborators (for both phase 1 and phase 2 to date) are listed below:

 The iSAEC thanks all of its members and collaborators for their efforts and contributions to our efforts to understand the genetic/molecular basis of drug induced serious adverse events.